Proposed Data Collections Submitted for Public Comment and Recommendations, 58391-58392 [2010-24021]
Download as PDF
Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices
Facility: Vitro Manufacturing.
Location: Canonsburg, Pennsylvania.
Job Titles and/or Job Duties: All
employees who worked in any area.
Period of Employment: January 1,
1958 through April 30, 1960.
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Interim Director,
Division of Compensation Analysis and
Support, National Institute for
Occupational Safety and Health
(NIOSH), 4676 Columbia Parkway, MS
C–46, Cincinnati, OH 45226, Telephone
877–222–7570. Information requests can
also be submitted by e-mail to
DCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2010–24011 Filed 9–23–10; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–10–0527]
srobinson on DSKHWCL6B1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
VerDate Mar<15>2010
16:12 Sep 23, 2010
Jkt 220001
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Human Exposure to Cyanobacterial
Toxins in Water (OMB No. 0920–0527
exp. 2/28/2011)—Revision—National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Cyanobacteria (also called blue-green
algae) can be found in terrestrial, fresh,
brackish, or marine water environments.
Some species of cyanobacteria produce
toxins that may cause acute or chronic
illnesses (including neurotoxicity,
hepatotoxicity, and skin irritation) in
humans and animals (including other
mammals, fish, and birds). A number of
human health effects, including
gastroenteritis, respiratory effects, skin
irritations, allergic responses, and liver
damage, are associated with the
ingestion of or contact with water
containing cyanobacterial blooms.
Although the balance of evidence, in
conjunction with data from laboratory
animal research, suggests that
cyanobacterial toxins are responsible for
a range of human health effects, there
have been few epidemiologic studies of
this association.
In the first study of recreational
microcystin (MC) exposure at a small
lake, 104 study participants from lake
visitors planning recreational activities
that would generate aerosols were
recruited, such as boating and using
personal watercraft. During data
collection for that study, MC
concentrations within the bloom lake
water were very low (<2–5 μg/L). Study
participants’ plasma MC concentrations
were all below the limit of detection
(0.147 μg/L) for the enzyme-linked
immunosorbent assay (ELISA). The
second study of recreational exposure to
microcystins involved 81 children and
adults planning recreational activities
on one of three California reservoirs,
two with significant, ongoing blooms of
toxin-producing cyanobacteria,
including Microcystis aeruginosa
(bloom lakes) and one without a toxinproducing algal bloom (control lake).
Highly variable microcystin
concentrations were found in bloom
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
58391
lakes (<10 μg/L to > 500 μg/L);
microcystin was not detected in control
lake samples. Neither adenoviruses nor
enteroviruses were detected in any of
the lakes. Low microcystin
concentrations were found in personal
air samples (< 0.1 ng/m3 [limit of
detection]—2.89 ng/m3) and nasal
swabs (< 0.1 ng [limit of detection]—5
ng). Microcystin concentrations in the
water-soluble fraction of all plasma
samples were below the limit of
detection (1.0 μg/L). Findings indicate
that recreational activities in
waterbodies experiencing toxinproducing cyanobacterial blooms can
generate aerosolized cyanotoxins,
making inhalation a potential route of
exposure.
Based on earlier work, it seems
unlikely that recreational exposure to
cyanobacteria toxins during algal
blooms on small lakes will cause acute
illness in people. However, there are
occupational circumstances, such as
using stagnant ponds to irrigate
landscapes or golf courses and growing
and harvesting catfish in standing
ambient water ponds, where exposure to
these toxins is likely to be greater than
what have been observed during
recreational activities. It is possible that
these workers may be exposed to
biologically relevant concentrations of
cyanobacterial toxins while performing
job-related activities. To address this
concern, this proposal is to assess
exposure of catfish farm workers to
cyanobacteria toxins occurring in the
standing water of catfish ponds in
Alabama. Dr. Alan Wilson of Auburn
University will be a collaborator. Dr.
Wilson has considerable experience
working with the catfish farmers to
address how the presence of
cyanobacteria in pond water can impact
the taste and odor of catfish offered for
sale to commercial markets. Since most
of the ponds of interest tend to develop
HABs comprising Microcystis
aeruginosa, this study will be limited to
exposure to microcystins.
The purpose of the new data
collection is to continue assessing the
public health impact of exposure to the
cyanobacterial toxins, microcystins. The
extent of human exposure to
microcystins present in catfish pond
waters and associated aerosols and
whether serum levels of microcystins
can be used as a biomarker of exposure
will be examined.
E:\FR\FM\24SEN1.SGM
24SEN1
58392
Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Screening Questionnaire .............
60
1
5/60
5
Pre-exposure Questionnaire .......
50
1
10/60
8
Post-exposure Questionnaire ......
50
4
10/60
33
......................................................
........................
........................
....................
46
Respondents
Form name
Catfish farm workers ......................................
Total ........................................................
Dated: September 20, 2010.
Thelma E. Sims,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–24021 Filed 9–23–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Voluntary Customer
Satisfaction Surveys To Implement
Executive Order 12862 in the Substance
Abuse and Mental Health Services
Administration (SAMHSA)—(OMB No.
0930–0197)—Extension
Executive Order 12862 directs
agencies that ‘‘provide significant
services directly to the public’’ to
‘‘survey customers to determine the kind
and quality of services they want and
their level of satisfaction with existing
services.’’ SAMHSA provides significant
services directly to the public, including
treatment providers and State substance
abuse and mental health agencies,
through a range of mechanisms,
including publications, training,
meetings, technical assistance and Web
sites. Many of these services are focused
on information dissemination activities.
Number of
respondents
Type of data collection
Total
burden
hours
The purpose of this submission is to
extend the existing generic approval for
such surveys.
The primary use for information
gathered is to identify strengths and
weaknesses in current service
provisions by SAMHSA and to make
improvements that are practical and
feasible. Several of the customer
satisfaction surveys expected to be
implemented under this approval will
provide data for measurement of
program effectiveness under the
Government Performance and Results
Act (GPRA). Information from these
customer surveys will be used to plan
and redirect resources and efforts to
improve or maintain a high quality of
service to health care providers and
members of the public. Focus groups
may be used to develop the survey
questionnaire in some instances.
The estimated annual hour burden is
as follows:
Responses/
respondent
Hours/
response
Total hours
250
89,750
1
1
2.50
.250
625
22,438
Total ..........................................................................................................
srobinson on DSKHWCL6B1PROD with NOTICES
Focus groups ...................................................................................................
Self-administered, mail, telephone and e-mail surveys ...................................
90,000
........................
........................
23,063
Written comments and
recommendations concerning the
proposed information collection should
be sent by October 25, 2010 to:
SAMHSA Desk Officer, Human
Resources and Housing Branch, Office
of Management and Budget, New
Executive Office Building, Room 10235,
Washington, DC 20503; due to potential
delays in OMB’s receipt and processing
of mail sent through the U.S. Postal
Service, respondents are encouraged to
submit comments by fax to: 202–395–
7285.
Dated: September 16, 2010.
Elaine Parry,
Director, Office of Management, Technology
and Operations.
[FR Doc. 2010–23932 Filed 9–23–10; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
VerDate Mar<15>2010
16:12 Sep 23, 2010
Jkt 220001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995, Pub.
L. 104–13), the Health Resources and
Services Administration (HRSA)
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Officer at (301) 443–
1129.
Comments are invited on: (a) The
proposed collection of information for
the proper performance of the functions
of the Agency; (b) the accuracy of the
E:\FR\FM\24SEN1.SGM
24SEN1
Agencies
[Federal Register Volume 75, Number 185 (Friday, September 24, 2010)]
[Notices]
[Pages 58391-58392]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-24021]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-10-0527]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Human Exposure to Cyanobacterial Toxins in Water (OMB No. 0920-0527
exp. 2/28/2011)--Revision--National Center for Environmental Health
(NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Cyanobacteria (also called blue-green algae) can be found in
terrestrial, fresh, brackish, or marine water environments. Some
species of cyanobacteria produce toxins that may cause acute or chronic
illnesses (including neurotoxicity, hepatotoxicity, and skin
irritation) in humans and animals (including other mammals, fish, and
birds). A number of human health effects, including gastroenteritis,
respiratory effects, skin irritations, allergic responses, and liver
damage, are associated with the ingestion of or contact with water
containing cyanobacterial blooms. Although the balance of evidence, in
conjunction with data from laboratory animal research, suggests that
cyanobacterial toxins are responsible for a range of human health
effects, there have been few epidemiologic studies of this association.
In the first study of recreational microcystin (MC) exposure at a
small lake, 104 study participants from lake visitors planning
recreational activities that would generate aerosols were recruited,
such as boating and using personal watercraft. During data collection
for that study, MC concentrations within the bloom lake water were very
low (<2-5 [mu]g/L). Study participants' plasma MC concentrations were
all below the limit of detection (0.147 [mu]g/L) for the enzyme-linked
immunosorbent assay (ELISA). The second study of recreational exposure
to microcystins involved 81 children and adults planning recreational
activities on one of three California reservoirs, two with significant,
ongoing blooms of toxin-producing cyanobacteria, including Microcystis
aeruginosa (bloom lakes) and one without a toxin-producing algal bloom
(control lake). Highly variable microcystin concentrations were found
in bloom lakes (<10 [mu]g/L to > 500 [mu]g/L); microcystin was not
detected in control lake samples. Neither adenoviruses nor
enteroviruses were detected in any of the lakes. Low microcystin
concentrations were found in personal air samples (< 0.1 ng/m\3\ [limit
of detection]--2.89 ng/m\3\) and nasal swabs (< 0.1 ng [limit of
detection]--5 ng). Microcystin concentrations in the water-soluble
fraction of all plasma samples were below the limit of detection (1.0
[mu]g/L). Findings indicate that recreational activities in waterbodies
experiencing toxin-producing cyanobacterial blooms can generate
aerosolized cyanotoxins, making inhalation a potential route of
exposure.
Based on earlier work, it seems unlikely that recreational exposure
to cyanobacteria toxins during algal blooms on small lakes will cause
acute illness in people. However, there are occupational circumstances,
such as using stagnant ponds to irrigate landscapes or golf courses and
growing and harvesting catfish in standing ambient water ponds, where
exposure to these toxins is likely to be greater than what have been
observed during recreational activities. It is possible that these
workers may be exposed to biologically relevant concentrations of
cyanobacterial toxins while performing job-related activities. To
address this concern, this proposal is to assess exposure of catfish
farm workers to cyanobacteria toxins occurring in the standing water of
catfish ponds in Alabama. Dr. Alan Wilson of Auburn University will be
a collaborator. Dr. Wilson has considerable experience working with the
catfish farmers to address how the presence of cyanobacteria in pond
water can impact the taste and odor of catfish offered for sale to
commercial markets. Since most of the ponds of interest tend to develop
HABs comprising Microcystis aeruginosa, this study will be limited to
exposure to microcystins.
The purpose of the new data collection is to continue assessing the
public health impact of exposure to the cyanobacterial toxins,
microcystins. The extent of human exposure to microcystins present in
catfish pond waters and associated aerosols and whether serum levels of
microcystins can be used as a biomarker of exposure will be examined.
[[Page 58392]]
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total
Respondents Form name respondents responses per response burden
respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Catfish farm workers............. Screening 60 1 5/60 5
Questionnaire.
------------------------------------------------------------------------------
Pre-exposure 50 1 10/60 8
Questionnaire.
------------------------------------------------------------------------------
Post-exposure 50 4 10/60 33
Questionnaire.
------------------------------------------------------------------------------
Total........................ ................... .............. .............. ........... 46
----------------------------------------------------------------------------------------------------------------
Dated: September 20, 2010.
Thelma E. Sims,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-24021 Filed 9-23-10; 8:45 am]
BILLING CODE 4163-18-P